{"id":346,"date":"2015-02-23T09:04:55","date_gmt":"2015-02-23T14:04:55","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=346"},"modified":"2015-02-23T17:37:49","modified_gmt":"2015-02-23T22:37:49","slug":"secondary-announced-2-23-2015","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondary-announced-2-23-2015\/","title":{"rendered":"Secondaries announced 2.23.2015"},"content":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating.<\/p>\n<p>Company: <strong>QTS Realty Trust, Inc.<\/strong><br \/>\nSymbol: QTS<br \/>\nPrice: Last trade $37.65<br \/>\nTrade Date: 2\/25<br \/>\nShares: 8.7 million<br \/>\nUnderwriter(s) Jefferies, BofA Merrill Lynch, Deutsche Bank Securities, Goldman Sachs, J.P. Morgan, KeyBanc Capital Markets, Morgan Stanley<br \/>\nCo Manager(s) Evercore, Stifel, Baird, PNC, SunTrust Robinson Humphrey<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Summit Therapeutics<\/strong><br \/>\nSymbol: SMMT<br \/>\nPrice: $11.54-$11.54<br \/>\nDescription: They are a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies. Their ordinary shares are admitted for trading on AIM, a market operated by the London Stock Exchange plc, or AIM, under the listing code &#8216;SUMM&#8217;. On February 19, 2015, the last reported sale price of our ordinary shares on AIM was 1.50 pounds per share, which is equivalent to $11.54 per ADS based on an assumed exchange rate of 1.00 pound to $1.5394.<br \/>\nTrade Date: 3\/5<br \/>\nShares: 3.45 million ADS<br \/>\nUnderwriter(s) JMP Securities, Oppenheimer &amp; Co.<br \/>\nCo Manager(s) Needham &amp; Company<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Xencor, Inc.<\/strong><br \/>\nSymbol: XNCR<br \/>\nPrice: Last trade $15.32<br \/>\nTrade Date: 2\/25<br \/>\nShares: 5.5 million<br \/>\nUnderwriter(s) Leerink Partners<br \/>\nCo Manager(s) Wedbush PacGrow Life Sciences, Oppenheimer &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Health Care Reit<\/strong><br \/>\nSymbol: HCN<br \/>\nPrice: Last trade $78.68<br \/>\nTrade Date: 2\/24<br \/>\nShares: 17 million<br \/>\nUnderwriter(s) Goldman Sachs, Barclays, UBS Investment Bank, Wells Fargo Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company:<strong> Tallgrass Energy Partners, LP<\/strong><br \/>\nSymbol: TEP<br \/>\nPrice: Last trade $52.58<br \/>\nTrade Date: 2\/24<br \/>\nShares: 10 million<br \/>\nUnderwriter(s) BofA Merrill Lynch, Deutsche Bank Securities, Barclays, Citigroup, Credit Suisse, Goldman Sachs, Morgan Stanley, RBC Capital Markets, Wells Fargo Securities<br \/>\nCo Manager(s) BBVA Capital One Securities, Regions Securities<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Boot Barn Holdings, Inc.<\/strong><br \/>\nSymbol: BOOT<br \/>\nPrice: Last trade $22.27<br \/>\nTrade Date: 2\/26<br \/>\nShares: 4.5 million<br \/>\nUnderwriter(s) J.P. Morgan, Piper Jaffray, Jefferies<br \/>\nCo Manager(s) Wells Fargo Securities, Baird<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Arista Networks, Inc.-BLOCK<\/strong><br \/>\nSymbol: ANET<br \/>\nPrice: Last trade $69.05<br \/>\nTrade Date: 2\/24<br \/>\nShares: 2.5 million<br \/>\nUnderwriter(s) Morgan Stanley<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n<p>Company: <strong>Q2 Holdings, Inc.<\/strong><br \/>\nSymbol: QTWO<br \/>\nPrice: Last trade $20.33<br \/>\nTrade Date: 2\/27<br \/>\nShares: 4.6 million<br \/>\nUnderwriter(s) J.P. Morgan, Morgan Stanley, Stifel<br \/>\nCo Manager(s) Raymond James, Canaccord Genuity, Needham &amp; Co.<br \/>\n<a href=\" https:\/\/www.ipoboutique.com\/Subscribe.html\">Rating=Subscription Needed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPOBoutique.Com rates secondary offerings to hit the tape with a \u2018BUY\u2019, \u2018NEUTRAL\u2019 or \u2018AVOID\u2019 rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary\u2019s he\u2019s issued with a \u2018BUY\u2019 rating. Company: QTS Realty Trust, Inc. Symbol: QTS Price: Last trade $37.65 Trade Date: 2\/25 Shares: 8.7 million Underwriter(s) Jefferies, BofA Merrill Lynch,[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[124,148,146,143,149,144,147,145],"class_list":["post-346","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings","tag-anet","tag-boot","tag-hcn","tag-qts","tag-qtwo","tag-smmt","tag-tep","tag-xncr"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=346"}],"version-history":[{"count":7,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/346\/revisions"}],"predecessor-version":[{"id":350,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/346\/revisions\/350"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}